PetIQ PE Ratio 2016-2019 | PETQ

Current and historical p/e ratio for PetIQ (PETQ) from 2016 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. PetIQ PE ratio as of September 20, 2019 is 17.47.
PetIQ PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-09-20 27.23 129.67
2019-06-30 32.96 $0.21 156.95
2019-03-31 31.41 $0.20 157.05
2018-12-31 23.47 $-0.01 0.00
2018-09-30 39.31 $-0.10 0.00
2018-06-30 26.86 $-0.25 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.740B $0.529B
PetIQ, Inc. is a pet medication and wellness company. Its product consists of Rx Medications, OTC Medications and Supplies, Health and Wellness Products. The Company serves retail stores across the mass, club, grocery, pharmacy and e-commerce channels. PetIQ, Inc. is based in Eagle, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.825B 27.79
Medtronic (MDT) Ireland $147.584B 20.72
Stryker (SYK) United States $82.482B 28.52
Boston Scientific (BSX) United States $59.759B 28.99
Baxter (BAX) United States $44.643B 27.07
EssilorLuxottica Societe Anonyme (ESLOY) France $31.425B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.623B 18.32
Coloplast (CLPBY) Denmark $25.682B 41.00
Lonza Group Ag (LZAGY) Switzerland $25.628B 0.00
Terumo (TRUMY) Japan $22.710B 26.11
Smith & Nephew SNATS (SNN) United Kingdom $20.792B 0.00
ResMed (RMD) United States $19.048B 36.32
Sunny Optical Technology (SNPTF) China $16.288B 0.00
Bio-Rad Laboratories (BIO) United States $10.082B 54.05
Canopy Growth (CGC) Canada $10.015B 0.00
Insulet (PODD) United States $8.923B 528.71
Perrigo (PRGO) Ireland $7.527B 13.86
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.973B 20.79
Haemonetics (HAE) United States $6.488B 48.96
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.377B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.192B 0.00
Neogen (NEOG) United States $4.086B 67.83
NuVasive (NUVA) United States $3.383B 26.97
ICU Medical (ICUI) United States $3.322B 21.55
Hutchison China MediTech (HCM) China $2.766B 0.00
Quidel (QDEL) United States $2.645B 26.26
Agios Pharmaceuticals (AGIO) United States $2.144B 0.00
National Vision Holdings (EYE) United States $2.086B 45.03
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.577B 0.00
VAREX IMAGING (VREX) United States $1.099B 25.32
AtriCure (ATRC) United States $1.000B 0.00
Lantheus Holdings (LNTH) United States $0.999B 26.25
Omeros (OMER) United States $0.912B 0.00
Phibro Animal Health (PAHC) United States $0.882B 14.34
NanoString Technologies (NSTG) United States $0.807B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.793B 20.22
Cerus (CERS) United States $0.744B 0.00
LeMaitre Vascular (LMAT) United States $0.710B 42.09
MacroGenics (MGNX) United States $0.631B 0.00
Surmodics (SRDX) United States $0.623B 118.46
TG Therapeutics (TGTX) United States $0.609B 0.00
Quanterix (QTRX) United States $0.598B 0.00
OraSure Technologies (OSUR) United States $0.463B 21.43
Meridian Bioscience (VIVO) United States $0.413B 12.88
BioLife Solutions (BLFS) United States $0.399B 131.13
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.373B 0.00
Utah Medical Products (UTMD) United States $0.371B 27.17
Owens & Minor (OMI) United States $0.353B 10.59
Zynex (ZYXI) United States $0.304B 32.28
United Health Products (UEEC) United States $0.293B 0.00
Bovie Medical (APYX) United States $0.239B 0.00
Rockwell Medical (RMTI) United States $0.213B 0.00
Cytosorbents (CTSO) United States $0.174B 0.00
Vapotherm (VAPO) United States $0.171B 0.00
Chimerix (CMRX) United States $0.146B 0.00
Fonar (FONR) United States $0.143B 10.19
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.120B 0.00
InfuSystems Holdings (INFU) United States $0.102B 0.00
United-Guardian (UG) United States $0.088B 20.88
MRI Interventions (MRIC) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Surface Oncology (SURF) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00